> GlaxoSmithKline ($GSK) completed its acquisition of Novartis' ($NVS) vaccine business. Story
> Galena Biopharma announced positive Phase IIa results of its GALE-301 immunotherapy in preventing the recurrence of ovarian and endometrial cancers. Galena also identified an optimal dose. Statement
> Aduro ($ADRO), through a $32 million purchase of Dutch biotech BioNovion, added an in-house preclinical pipeline of antibodies and checkpoint inhibitors. Report
> Researchers at the University of Rochester Medical Center received $3.1 million from the NIH to look for new ways to develop an HIV vaccine. Release